The Etomidate (ETO) Rapid Test is a lateral flow immunoassay for the qualitative detection of Etomidate in human urine. Quick, accurate, and easy to use.
The ETO Rapid Test Dipstick is intended for professional in vitro diagnostic use only. It detects N,N-Dimethyltyramine (Etomidate) at a cut-off concentration of 1,000 ng/mL in urine samples. It may also detect related compounds, as indicated in the product’s analytical specificity table. For confirmation of presumptive positive results, more specific laboratory techniques such as gas chromatography-mass spectrometry (GC-MS) are recommended. Professional discretion is advised when interpreting results.
Etomidate is a short-acting anesthetic commonly used in surgical procedures due to its cardio-stable properties. However, since being designated as a controlled substance in several countries, cases of misuse and abuse have increased. Side effects such as myoclonus, regurgitation, and complications in patients with certain conditions have raised clinical concern. As misuse trends rise, quick and reliable screening tools like this rapid test are vital for identifying exposure and preventing further harm.
The ETO Rapid Test utilizes competitive binding to detect Etomidate in urine. During testing, the sample migrates through the test strip by capillary action. If Etomidate is present in the sample above the cut-off level, it will bind to antibody-coated particles, preventing the formation of a visible test line. A drug-negative sample produces a test line, while a positive sample will not, due to antibody saturation. A control line always appears, confirming that the test was performed correctly and that sufficient sample volume was applied.
Etomidate (ETO) Rapid Urine Drug Test is available in three convenient formats to suit various testing environments and workflows: